Sunday, April 26, 2026
wellness India Expo
Home Tags COVID-19

Tag: COVID-19

Universal COVID-19 vaccine can be game-changer for developing countries like India,...

The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine

Survivors of acute Covid-19 at increased risk of psychiatric disorders

Patients who got infected with mild to medium case of Covid and successfully recovered are now suffering from what is being called as the Long Covid Syndrome

Heart attack diagnostics market sales create significant incremental opportunity over 2032

The COVID-19 pandemic has substantially influenced the market for heart attack diagnoses

Japan’s homegrown COVID-19 mRNA vaccine needs superior safety & efficacy data...

In 2021, leading mRNA vaccines, Comirnaty and Spikevax, generated combined sales of more than $54 billion globally and are expected to generate similar or greater sales in 2022

Electrosurgery devices market to witness a CAGR of 4% through 2031

Electrosurgery has evolved over the past several decades and is now the leading form of energy in both open and laparoscopic surgery

AstraZeneca likely to see substantial Evusheld uptake in Japan, says GlobalData

The government’s decision to limit the drug’s supply to only COVID-19 prevention will still likely encourage its uptake, says GlobalData, a leading data and analytics company

Bharat Biotech’s iNCOVACC, world’s first Intra Nasal vaccine, gets emergency use...

Heterologous booster dose studies were conducted for safety and immunogenicity in ~875 subjects at 9 trial sites across India

Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene partnership with Bharat Biotech &...

An entirely new “chimeric” spike antigen complex, different from any protein of existing SARS-CoV-2 variants, will be generated

Post DCGI approval, Gennova to produce 40-50 lakh doses of GEMCOVAC-19...

To be sold under the brand name GEMCOVAC™-19, the two dose vaccine will be available for adults above 18 years of age and administered intramuscularly at 28 days apart

National Doctors’ Day: Medical fraternity gained first-hand experience during pandemic

Leading doctors share their experiences and learnings from the pandemic